KR860007927A - 혈관 보호 제약 조성물 - Google Patents

혈관 보호 제약 조성물 Download PDF

Info

Publication number
KR860007927A
KR860007927A KR1019860003298A KR860003298A KR860007927A KR 860007927 A KR860007927 A KR 860007927A KR 1019860003298 A KR1019860003298 A KR 1019860003298A KR 860003298 A KR860003298 A KR 860003298A KR 860007927 A KR860007927 A KR 860007927A
Authority
KR
South Korea
Prior art keywords
pharmaceutical composition
compound
vascular protective
composition according
protective action
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1019860003298A
Other languages
English (en)
Korean (ko)
Inventor
브라세이 피에레-노엘
Original Assignee
이보 벡크.
세우레프 에이. 지.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 이보 벡크., 세우레프 에이. 지. filed Critical 이보 벡크.
Publication of KR860007927A publication Critical patent/KR860007927A/ko
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/15—Suppositories

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
KR1019860003298A 1985-04-30 1986-04-29 혈관 보호 제약 조성물 Ceased KR860007927A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH01826/85-7 1985-04-30
CH1826/85A CH662505A5 (it) 1985-04-30 1985-04-30 Composizioni farmaceutiche ad azione protettiva vascolare.

Publications (1)

Publication Number Publication Date
KR860007927A true KR860007927A (ko) 1986-11-10

Family

ID=4219499

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019860003298A Ceased KR860007927A (ko) 1985-04-30 1986-04-29 혈관 보호 제약 조성물

Country Status (10)

Country Link
US (1) US4707360A (enExample)
JP (1) JPS61280424A (enExample)
KR (1) KR860007927A (enExample)
AT (1) AT393793B (enExample)
BE (1) BE904696A (enExample)
CH (1) CH662505A5 (enExample)
DE (1) DE3614278A1 (enExample)
FR (1) FR2587212B1 (enExample)
GB (2) GB8610147D0 (enExample)
NL (1) NL8601105A (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0383171A3 (en) * 1989-02-11 1991-07-24 Hoechst Aktiengesellschaft 2,3,23-trihydroxy-urs-12-ene derivatives for treating cognitive disorders
FR2645442A1 (fr) * 1989-04-07 1990-10-12 Gueyne Jean Produit therapeutique a base de compose organique du silicium et de polyamine polycarboxylee, particulierement utile pour le traitement de l'atherome
GB8926715D0 (en) * 1989-11-28 1990-01-17 Haessle Ab Improvements relating to the administration of pharmaceutical agents
EP0526578A4 (en) * 1990-04-26 1993-09-22 Cytrx Corporation Composition and method for topical treatment of damaged or diseased tissue
FR2661830B1 (fr) * 1990-05-11 1992-09-04 Corbiere Jerome Nouvelle compositions pharmaceutiques a base de flavonoside.
US5234914A (en) * 1991-06-11 1993-08-10 Patent Biopharmaceutics, Inc. Methods of treating hemorrhoids and anorecial disease
US5399584A (en) * 1992-05-05 1995-03-21 The Procter & Gamble Company Use of flavone derivatives for gastroprotection
FR2692145B1 (fr) * 1992-06-10 1995-05-05 Bellon Labor Sa Roger Nouvelle composition à usage topique contenant de la diosmine.
IT1265312B1 (it) * 1993-12-21 1996-10-31 Indena Spa Formulazioni contenenti carotenoidi e procarotenoidi associati a polifenoli nella prevenzione dei danni da abnorme produzione di
GB9425487D0 (en) * 1994-12-16 1995-02-15 Res Inst Osteoarthritis treatment
US5683678A (en) * 1995-03-09 1997-11-04 The Procter & Gamble Company Oral compositions
US6169112B1 (en) * 1996-11-27 2001-01-02 Dong Kook Pharmaceutical Co., Ltd. Medicines for treating dementia or cognitive disorder, which comprises asiatic acid derivatives
KR100530278B1 (ko) 1997-02-28 2006-04-06 동국제약 주식회사 아시아트산 유도체를 유효성분으로 하는 간 보호 및치료제
US6077534A (en) * 1997-09-02 2000-06-20 Klinge Pharma Gmbh Production of pharmaceutical formulations for treatment of edema and venous disorders
US6159494A (en) * 1997-12-03 2000-12-12 Widgerow; Alan D Treatment of post operative scars with a tape containing a gel from Bulbine frutescens
US6562864B1 (en) 1999-09-02 2003-05-13 Drake Larson Catechin multimers as therapeutic drug delivery agents
US6423742B1 (en) 1999-09-02 2002-07-23 Drake Larson Compositions for reducing vascular plaque formation and methods of using same
ES2235953T3 (es) * 1999-09-10 2005-07-16 Ceteris Holding B.V.-Amsterdam (Olanda) - Succursale Di Lugano Una preparacion antioxidante basada en extractos de plantas para el tratamiento de la hipertension y de problemas degenerativos cronicos y de circulacion.
EP1214084B1 (en) 1999-09-10 2005-04-06 Ceteris Holding B.V.-Amsterdam (Olanda) - Succursale di Lugano An anti-oxidant preparation based on plant extracts for the treatment of circulation and adiposity problems
EP1370272A1 (en) * 2001-03-02 2003-12-17 Biopharmacopae Design International Inc. Inhibitors of extracellular proteases
JP2002293736A (ja) * 2001-03-30 2002-10-09 Sunstar Inc メーラード反応阻害剤およびそれを含有する組成物
DE20109044U1 (de) * 2001-05-30 2001-08-09 Weber & Weber GmbH & Co. KG, 82266 Inning Pharmazeutische Zubereitung
US6981883B2 (en) * 2001-11-14 2006-01-03 Fci Americas Technology, Inc. Impedance control in electrical connectors
US8758743B2 (en) * 2003-01-17 2014-06-24 Taiyo Kagaku Co., Ltd. Compositions containing coenzyme Q10
EP1819356A4 (en) * 2004-11-18 2010-07-07 Biopharmacopae Design Internat PLANT EXTRACTS AND THEIR USES IN DERMATOLOGY
US20070010459A1 (en) * 2005-01-14 2007-01-11 Ying Liu Application of asiatic acid and its derivatives to treat pulmonary fibrosis
US8591961B2 (en) 2008-09-04 2013-11-26 Allergan, Inc. Aesthetic treatment of scars and aging skin
US8071139B2 (en) * 2008-09-04 2011-12-06 Alan David Widgerow Treatment of damaged skin
EP2353596A1 (en) * 2010-02-02 2011-08-10 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Combination composition, comprising as active ingredients L-carnitine or propionyl L-carnitine, for the prevention or treatment of chronic venous insufficiency

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1157269B (it) * 1982-03-19 1987-02-11 Seuref Ag Nuove formulazioni farmaceutiche contenenti il coenzima q10 adatte per la somministrazione topica
CH655005A5 (it) * 1983-02-16 1986-03-27 Sigma Tau Ind Farmaceuti Composizione farmaceutica ad azione metabolica ed energetica utilizzabile in terapia cardiaca e vascolare.
CH670763A5 (enExample) * 1985-08-02 1989-07-14 Seuref Ag

Also Published As

Publication number Publication date
CH662505A5 (it) 1987-10-15
ATA115186A (de) 1991-06-15
GB2174904A (en) 1986-11-19
NL8601105A (nl) 1986-11-17
GB8610147D0 (en) 1986-05-29
FR2587212A1 (fr) 1987-03-20
GB2174904B (en) 1989-07-05
AT393793B (de) 1991-12-10
FR2587212B1 (fr) 1992-05-29
BE904696A (nl) 1986-08-18
JPS61280424A (ja) 1986-12-11
GB8610588D0 (en) 1986-06-04
JPH0344048B2 (enExample) 1991-07-04
US4707360A (en) 1987-11-17
DE3614278A1 (de) 1986-10-30

Similar Documents

Publication Publication Date Title
ES2115135T3 (es) Valvula de varias vias.
BRPI9914741A (pt) n-(2-aril-proprionil)-sulfonamidas, usos e composições farmacêuticas contendo as mesmas.
ATE62249T1 (de) Homodisaccharide hypoglycemische mittel.
AU4916979A (en) Sugar derivatives of c-076 compounds
DE3686975D1 (de) Zusammensetzung auf basis von glucomannanen und polyhydrischen alkoholen und daraus hergestellter film.
HUP0001640A2 (hu) N6-helyzetben heterociklusosan szubsztituált adenozinszármazékok, alkalmazásuk gyógyszerkészítmények előállítására és ezeket tartalmazó gyógyszerkészítmények
FI890039A0 (fi) Foerfarande och anordning foer svepning av plastfolie runt en vara.
IT1216827B (it) Composizioni farmaceutiche con azione sistemica, applicabili in modo topico
BE884743A (fr) Sels de la (+)-catechine, leur preparation et utilisation ainsi que composition contenant ces sels.
DE3583334D1 (de) Borverbindungen enthaltende polycarbonatzusammensetzungen.
IT1203791B (it) Derivati del morfinano e della morfina,loro preparazione,loro impiego come medicamenti e e le composizioni farmaceutiche che li contengono
DE3680749D1 (de) Makrolid-antibiotikaderivate.
GB1469861A (en) O-aminoalkyl-glucose and galactose derivatives
NZ212673A (en) Avermectin and milbemycin derivatives and parasiticidal compositions
ATE54956T1 (de) Korrosionsinhibierte abschreckmittel.
FI885852A7 (fi) Anordning foer sluta en foerpackning runt en vara, som skall foerpackas.
FI875354A7 (fi) Sytostaattisesti vaikuttavat antrasykliinijohdannaiset.
FI854285A7 (fi) Anticoccidial komposition, foder foer fjaederfae, foerfarande foer framstaellning av foder foer fjaederfae, foerfarande foer skoetsel av fjaederfae, foerfarande foer uppfoedning av faoglar, foerfarande foer framstaellning av isoxazoler och nya isoxazoler.
ES2152947T3 (es) Una cepa de streptomyces avermitilis y compuestos de avermectina glicosilados.
IT8548195A0 (it) Derivati della naftossazina, loro preparazione, loro applicazione come medicamenti e composizioni farmaceutiche che li contengono
ES465168A1 (es) Procedimiento de produccion de 3',4'-didesoxikanamicina bŸ
FI862022L (fi) Vinylesterharts, vilket frigoer endast en liten maengd styrene och vilket innehaoller polyakrylater, till anvaendning vid framstaellning av fiberfoerstaerkta produkter.
DZ1340A1 (fr) Nouveaux médicaments contenant des composés de s-oxyde de 1,2 dithiol-3-thione.
GB1090279A (en) Glucosides and galactosides
ATE90564T1 (de) Vitamin d glycoside.

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19860429

A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19861101

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19860429

Comment text: Patent Application

PG1501 Laying open of application
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19890522

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 19890908

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 19890522

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I